Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Molinari

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Neuroscience Letters|May 12, 2009
Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAsLucia Gatta, Alessio Cardinale, Francesca Wannenes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancerFederica Di Nicolantonio, Miriam Martini, Francesca Molinari, et al.
Italian Journal of Pediatrics|July 14, 2021
The Investigational Clinical Center: a clinical-supportive and patient-centered trial unit model. Ten years of experience through normal and pandemic times of a large pediatric trial center in ItalyGiuseppe Pontrelli, Marco Ciabattini, Franco De Crescenzo, et al.
Cancers|December 30, 2025
A Real-World Experience on the Efficacy of First-Line Treatment with Immune-Checkpoint Inhibitors in Non-Small-Cell Lung Cancer Patients with PD-L1 Expression ≥50%: The Role of <i>KRAS</i> MutationsLucia Motta, Samantha Epistolio, Jana Pankovics, et al.
Journal of Clinical Medicine|July 29, 2025
Prognostic Impact of KRAS-TP53 Co-Mutations in Patients with Early-Stage Non-Small Cell Lung Cancer: A Single-Center Retrospective StudyLucia Motta, Francesca Molinari, Jana Pankovics, et al.
Cellular and Molecular Life Sciences : CMLS|May 16, 2015
Apaf1-deficient cortical neurons exhibit defects in axonal outgrowthDaniela De Zio, Francesca Molinari, Salvatore Rizza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2012
KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumorsClaudia Miranda, Martina Nucifora, Francesca Molinari, et al.
Glycobiology|April 30, 2015
NEU3 activity enhances EGFR activation without affecting EGFR expression and acts on its sialylation levelsAlessandra Mozzi, Matilde Forcella, Alice Riva, et al.
Cancer Research|February 19, 2009
PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodiesAndrea Sartore-Bianchi, Miriam Martini, Francesca Molinari, et al.
Histology and Histopathology|October 15, 2013
EGFR, KRAS, BRAF, and PIK3CA characterization in squamous cell anal cancerVittoria Martin, Elena Zanellato, Alessandra Franzetti-Pellanda, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Neuroscience Letters|May 12, 2009
Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAsLucia Gatta, Alessio Cardinale, Francesca Wannenes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancerFederica Di Nicolantonio, Miriam Martini, Francesca Molinari, et al.
Italian Journal of Pediatrics|July 14, 2021
The Investigational Clinical Center: a clinical-supportive and patient-centered trial unit model. Ten years of experience through normal and pandemic times of a large pediatric trial center in ItalyGiuseppe Pontrelli, Marco Ciabattini, Franco De Crescenzo, et al.
Cancers|December 30, 2025
A Real-World Experience on the Efficacy of First-Line Treatment with Immune-Checkpoint Inhibitors in Non-Small-Cell Lung Cancer Patients with PD-L1 Expression ≥50%: The Role of <i>KRAS</i> MutationsLucia Motta, Samantha Epistolio, Jana Pankovics, et al.
Journal of Clinical Medicine|July 29, 2025
Prognostic Impact of KRAS-TP53 Co-Mutations in Patients with Early-Stage Non-Small Cell Lung Cancer: A Single-Center Retrospective StudyLucia Motta, Francesca Molinari, Jana Pankovics, et al.
Cellular and Molecular Life Sciences : CMLS|May 16, 2015
Apaf1-deficient cortical neurons exhibit defects in axonal outgrowthDaniela De Zio, Francesca Molinari, Salvatore Rizza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2012
KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumorsClaudia Miranda, Martina Nucifora, Francesca Molinari, et al.
Glycobiology|April 30, 2015
NEU3 activity enhances EGFR activation without affecting EGFR expression and acts on its sialylation levelsAlessandra Mozzi, Matilde Forcella, Alice Riva, et al.
Cancer Research|February 19, 2009
PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodiesAndrea Sartore-Bianchi, Miriam Martini, Francesca Molinari, et al.
Histology and Histopathology|October 15, 2013
EGFR, KRAS, BRAF, and PIK3CA characterization in squamous cell anal cancerVittoria Martin, Elena Zanellato, Alessandra Franzetti-Pellanda, et al.
Pageof 6